Get started
Author

K. E. Callon

Observed names: K E Callon, K.E. Callon, KE Callon, Karen E Callon
Observed institution: University of Auckland
OpenAlex ID: A5111978504
Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo
2002 · J Cornish, KE Callon, et al. · Journal of Endocrinology · 469
Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes
1999 · J. Cornish, K. E. Callon, et al. · American Journal of Physiology-Endocrinology and Metabolism · 101
Monosodium urate monohydrate crystals inhibit osteoblast viability and function: implications for development of bone erosion in gout
2011 · Ashika Chhana, Karen E Callon, et al. · Annals of the Rheumatic Diseases · 97
Preptin, another peptide product of the pancreatic β-cell, is osteogenic in vitro and in vivo
2006 · J. Cornish, K. E. Callon, et al. · American Journal of Physiology-Endocrinology and Metabolism · 85
Interleukin-18 Is a Novel Mitogen of Osteogenic and Chondrogenic Cells
2003 · J. Cornish, M. T. Gillespie, et al. · Endocrinology · 66
Systemic administration of adrenomedullin(27-52) increases bone volume and strength in male mice
2001 · J Cornish, KE Callon, et al. · Journal of Endocrinology · 36
PDF
Leukemia inhibitory factor is mitogenic to osteoblasts
1997 · J. Cornish, K.E. Callon, et al. · Bone · 32
Interleukin-18 is a novel mitogen of osteoblasts and chondrocytes
2002 · J. Cornish, Gillespie, et al. · Bone
Parathyroid hormone related peptide(107-139) inhibits bone resorption in vivo.
1996 · Jillian Cornish, K. E. Callon, et al. · Journal of Bone and Mineral Research
Works count: 10
Citation count: 886
H-index: 7
I10-index: 7
Year
Topic
Type